Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenoceptor-blocking agents: are pharmacologic differences relevant?

B J Clark

    American Heart Journal
    |August 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Unsupervised Phenotyping Reveals Disrupted Neural Firing Characteristics in the Anterior Thalamus and Surrounding Brain Regions Following Third-Trimester Equivalent Alcohol Exposure in Mice.

    bioRxiv : the preprint server for biology·2025
    Same author

    An Integrated Platform for in vivo Electrophysiology in Spatial Cognition Experiments.

    bioRxiv : the preprint server for biology·2023
    Same author

    Cue polarization and representation in mouse home base behaviors.

    Animal cognition·2022
    Same author

    Leydig cell insufficiency in hypospermatogenesis: a paracrine effect of activin-inhibin signaling?

    Andrology·2018
    Same author

    In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems.

    Pulmonary pharmacology & therapeutics·2016
    Same author

    Microemulsion high performance liquid chromatography (MELC) method for the determination of terbutaline in pharmaceutical preparation.

    Journal of pharmaceutical and biomedical analysis·2011
    Same journal

    Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

    American heart journal·2026
    Same journal

    Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

    American heart journal·2026
    Same journal

    Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

    American heart journal·2026
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    See all related articles

    Beta-adrenoceptor blockers vary in selectivity and stimulant activity. Some, like pindolol, show potential for fewer side effects due to intrinsic stimulant properties, impacting lung and vascular function.

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Respiratory Medicine

    Background:

    • Beta-adrenoceptor blockers are a diverse class of drugs.
    • Most exhibit membrane-stabilizing effects at high concentrations, lacking clinical relevance.
    • Some possess beta 1-selectivity or partial agonist activity, with controversial clinical importance.

    Purpose of the Study:

    • To evaluate the clinical relevance of beta-adrenoceptor blocker properties.
    • To investigate the impact of selectivity and partial agonism on therapeutic outcomes.
    • To explore the mechanisms behind differing side effect profiles.

    Main Methods:

    • Pharmacological characterization of beta-adrenoceptor blockers.
    • Analysis of clinical data regarding selectivity and partial agonism.

    Related Experiment Videos

  • Assessment of effects on lung function, vascular resistance, heart rate, and cardiac output.

    • Main Results:

    • Beta 1-selective agents (atenolol, metoprolol, practolol) show broad selectivity but no clear advantage over non-selective agents.
    • Therapeutic doses may exceed selective ranges, and tissues have mixed beta-receptor populations.
    • Partial agonists like pindolol maintain cardiac output and may reduce bronchopulmonary and vascular side effects.

    Conclusions:

    • Absolute receptor subtype specificity does not guarantee organ or tissue specificity.
    • Partial agonist activity in beta-blockers can counterbalance myocardial depression and improve cardiovascular and respiratory outcomes.
    • Pindolol's properties suggest a lower incidence of side effects, warranting further investigation.